Gary S. Lissner
Research Subjects
Research Interests
Gary S. Lissner has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Paul J. Bryar
Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL
2 shared publications Daina Variakojis
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA; Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
1 shared publicationGrace S. Zhang
Department of Ophthalmology, Northwestern University Chicago, IL 60611, USA
1 shared publication- Jane N. Winter
19Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
1 shared publication Karen Kaul
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA; Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Pathology and Laboratory Medicine, Evanston Northwestern Healthcare, Evanston, IL, USA
1 shared publication- Kathy A. Mangold
Department of Pathology, Endeavor Health, Evanston, IL 60201, USA
1 shared publication
Latest Publications
- 1 January 2007
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 48 (3) , 577-583
Lack of an association betweenChlamydia psittaciand ocular adnexal lymphoma
The objective of this study was to assess whether there is PCR evidence for C. psittaci DNA in ocular adnexal lymphoma specimens collected in an academic institution in the U.S. This was a retrospective, single-center study of patients from 1994 – 2004. We used 28 ocular adnexal lymphoma biopsy specimens from adult patients, 16 control lymphoma specimens from patients with systemic lymphomas not involving the ocular adnexa, and five control benign adnexal tissue samples. The presence of C. psittaci DNA was investigated by polymerase chain reaction (PCR) in each group. Two different assays were utilized: (1) conventional PCR/gel based assay targeting a 111-bp fragment of the 16S gene and (2) a real-time PCR assay amplifying a 148-bp portion of the 16S gene with detection via a specific fluorescent probe. Amplification was carried out to 60 cycles. Positive controls consisted of isolated DNA from C. psittaci strains VS1, CP3, and FP. A human DNA internal control was used to assess sample DNA quality and amplification success. Mean outcome measure was the presence of C. psittaci DNA. Using both assays, all patient samples in all categories yielded negative results. Both assays detected C. psittaci DNA from isolated strains. Internationally, Chlamydia psittaci has been associated with ocular adnexal lymphomas with great variability. Similar to several other recent studies in the USA, our study could not confirm the presence of C. psittaci in ocular adnexal lymphomas. Differences in the prevalence of C. psittaci infection in various geographic regions or technical differences in the application of the assays may underlie the variability in the association between C. psittaci and ocular adnexal lymphoma.
- 1 January 2007
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 48 (3) , 577-583
Lack of an association betweenChlamydia psittaciand ocular adnexal lymphoma
The objective of this study was to assess whether there is PCR evidence for C. psittaci DNA in ocular adnexal lymphoma specimens collected in an academic institution in the U.S. This was a retrospective, single-center study of patients from 1994 – 2004. We used 28 ocular adnexal lymphoma biopsy specimens from adult patients, 16 control lymphoma specimens from patients with systemic lymphomas not involving the ocular adnexa, and five control benign adnexal tissue samples. The presence of C. psittaci DNA was investigated by polymerase chain reaction (PCR) in each group. Two different assays were utilized: (1) conventional PCR/gel based assay targeting a 111-bp fragment of the 16S gene and (2) a real-time PCR assay amplifying a 148-bp portion of the 16S gene with detection via a specific fluorescent probe. Amplification was carried out to 60 cycles. Positive controls consisted of isolated DNA from C. psittaci strains VS1, CP3, and FP. A human DNA internal control was used to assess sample DNA quality and amplification success. Mean outcome measure was the presence of C. psittaci DNA. Using both assays, all patient samples in all categories yielded negative results. Both assays detected C. psittaci DNA from isolated strains. Internationally, Chlamydia psittaci has been associated with ocular adnexal lymphomas with great variability. Similar to several other recent studies in the USA, our study could not confirm the presence of C. psittaci in ocular adnexal lymphomas. Differences in the prevalence of C. psittaci infection in various geographic regions or technical differences in the application of the assays may underlie the variability in the association between C. psittaci and ocular adnexal lymphoma.
- 1 May 2003
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 121 (5) , 730-732
Bone Located Centrally Within a Dermolipoma
Case Report from JAMA Ophthalmology — Bone Located Centrally Within a Dermolipoma
- 1 May 2003
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 121 (5) , 730-732
Bone Located Centrally Within a Dermolipoma
Case Report from JAMA Ophthalmology — Bone Located Centrally Within a Dermolipoma